麦克奥迪：联合开发病理辅助诊断系统，解决基层医院病理医生资源不足等痛点

Core Viewpoint - The company is actively developing AI medical solutions to address challenges in pathology diagnosis, particularly in resource-limited settings [1] Group 1: Company Initiatives - The company's medical products include cell DNA ploidy analysis systems, automated screening systems for tuberculosis, automated diagnostic systems for malaria, and immunohistochemistry analysis systems [1] - The company is collaborating with domestic enterprises to develop a "pathology auxiliary diagnosis system" aimed at alleviating the shortage of pathology doctors and limited diagnostic experience in grassroots hospitals [1]